Literature DB >> 31789924

Meibomian Gland Dysfunction in a Hospital-Based Population in Central India.

Samrat Chatterjee1, Deepshikha Agrawal, Arpit Sharma.   

Abstract

PURPOSE: To estimate the prevalence of meibomian gland dysfunction (MGD) in a hospital-based population in India.
METHODS: This cross-sectional study screened 3410 subjects ≥20 years or older attending the outpatient department by systematic random sampling. The patients were subjected to a comprehensive eye examination, Ocular Surface Disease Index questionnaire, fluorescein tear film breakup time, Schirmer I test, lissamine green stain, lid margin changes, and meibomian gland expression. MGD was diagnosed when 1 or both of the following was present in at least 1 eye: reduced or absent meibum secretion and cloudy to inspissated toothpaste-like secretion on digital pressure over the eyelids.
RESULTS: The study included 570 subjects with a mean age of 49.3 ± 16.2 (20-84) years. MGD was diagnosed in 317 (55.61%) subjects, of whom 272 (47.7%) had only MGD and 45 (7.9%) had coexisting MGD and aqueous tear deficiency. The age-adjusted prevalence rate of MGD was 48.4% (95% confidence interval: 43.9-52.1). This rate increased significantly with age (P < 0.001) in both men (P < 0.001) and women (P < 0.001). The crude and age-adjusted prevalence of symptomatic MGD (Ocular Surface Disease Index score ≥13) was 26.1% (71/272) and 32.9% (95% confidence interval: 27.4-38.6), respectively. The prevalence of symptomatic MGD significantly declined with increasing age (P = 0.003), and this was reflected in both men (P = 0.013) and women (P = 0.179) but was not statistically significant in the latter.
CONCLUSIONS: The prevalence of MGD was higher in Indian subjects than that previously reported. Although the total MGD prevalence increased with age, the prevalence of symptomatic MGD decreased. Asymptomatic MGD was more common than symptomatic MGD.

Entities:  

Mesh:

Year:  2020        PMID: 31789924     DOI: 10.1097/ICO.0000000000002217

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  11 in total

1.  Prevalence, Severity, and Treatment Outcomes of Meibomian Gland Dysfunction in Patients With Dry Eye Symptoms at a Tertiary Care Center in South India.

Authors:  Jayanti Singh; Yamini Priya; Vivek Bhat
Journal:  Cureus       Date:  2022-06-07

2.  Evaluation of Meibomian Gland Dysfunction Among Ophthalmic Healthcare Workers.

Authors:  Alison Y Y Chan; Jasmine C Chuang; Victoria W Y Wong
Journal:  Clin Ophthalmol       Date:  2021-03-19

3.  Dry eye disease in India.

Authors:  Samrat Chatterjee; Deepshikha Agrawal; Arpit Sharma
Journal:  Indian J Ophthalmol       Date:  2020-07       Impact factor: 1.848

Review 4.  A review of meibography for a refractive surgeon.

Authors:  Krishna Poojita Vunnava; Naren Shetty; Kamal B Kapur
Journal:  Indian J Ophthalmol       Date:  2020-12       Impact factor: 1.848

5.  Factors influencing the clinical outcomes of intense pulsed light for meibomian gland dysfunction.

Authors:  Chen Chen; Di Chen; Yu-Yu Chou; Qin Long
Journal:  Medicine (Baltimore)       Date:  2021-12-10       Impact factor: 1.817

6.  Ocular Surface Disease Index© and the five-item dry eye questionnaire: A comparison in Indian patients with dry eye disease.

Authors:  Samrat Chatterjee; Deepshikha Agrawal; Pravda Chaturvedi
Journal:  Indian J Ophthalmol       Date:  2021-09       Impact factor: 1.848

7.  Orthokeratology Lens Wear for 2 Years in Children Did Not Alter Tear Film Lipid Thickness by Non-Invasive Interferometry.

Authors:  Haozhe Yu; Yifei Yuan; Wenyu Wu; Weizhen Zeng; Louis Tong; Yu Zhang; Yun Feng
Journal:  Front Med (Lausanne)       Date:  2022-02-10

8.  Short tear film breakup time-type of dry eye in India.

Authors:  Samrat Chatterjee; Deepshikha Agrawal
Journal:  Indian J Ophthalmol       Date:  2021-12       Impact factor: 1.848

9.  Noninvasive ocular surface analyzer as an adjunct in diagnosis and estimating prevalence of meibomian gland dysfunction: Hospital-based comparative study.

Authors:  Saumya Yadav; Noopur Gupta; Tarjani Makwana; Murugesan Vanathi; Radhika Tandon
Journal:  Indian J Ophthalmol       Date:  2022-05       Impact factor: 2.969

10.  Commentary: Meibomian gland dysfunction: Taking a deep dive into the ocular surface parameters.

Authors:  Purvasha Narang
Journal:  Indian J Ophthalmol       Date:  2022-05       Impact factor: 2.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.